Literature DB >> 27907277

HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline Summary From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology.

Angela N Bartley1, Mary Kay Washington1, Nofisat Ismaila1, Jaffer A Ajani1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27907277     DOI： 10.1200/JOP.2016.018929

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  2 in total

Review 1.  Evolution of predictive and prognostic biomarkers in the treatment of advanced gastric cancer.

Authors:  Nicole M Myer; Kohei Shitara; Hyun C Chung; Florian Lordick; Ronan J Kelly; Zsolt Szabo; Z Alexander Cao; Stephen Leong; David H Ilson; Wilko Weichert
Journal:  J Cancer Res Clin Oncol       Date:  2022-05-13       Impact factor: 4.322

2.  Physical basis of the 'magnification rule' for standardized Immunohistochemical scoring of HER2 in breast and gastric cancer.

Authors:  Andreas H Scheel; Frédérique Penault-Llorca; Wedad Hanna; Gustavo Baretton; Peter Middel; Judith Burchhardt; Manfred Hofmann; Bharat Jasani; Josef Rüschoff
Journal:  Diagn Pathol       Date:  2018-03-12       Impact factor: 2.644
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.